On Monday, Perspective Therapeutics Inc (AMEX: CATX) was -15.14% drop from the session before settling in for the closing price of $2.84. A 52-week range for CATX has been $1.60 – $5.39.
A company in the Healthcare sector has dropped its sales by -9.86% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -0.59%. With a float of $61.65 million, this company’s outstanding shares have now reached $74.34 million.
Perspective Therapeutics Inc (CATX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Perspective Therapeutics Inc stocks. The insider ownership of Perspective Therapeutics Inc is 17.07%, while institutional ownership is 63.26%. The most recent insider transaction that took place on Nov 13 ’25, was worth 22,295. In this transaction Chief Accounting Officer of this company bought 11,000 shares at a rate of $2.03, taking the stock ownership to the 59,800 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Director bought 9,498 for $2.10, making the entire transaction worth $19,946. This insider now owns 9,864 shares in total.
Perspective Therapeutics Inc (CATX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.24 earnings per share (EPS) during the time that was better than consensus figure (set at -0.25) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -0.59% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.62% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
You can see what Perspective Therapeutics Inc (CATX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 167.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.34 in one year’s time.
